September 1, 2020
BNN Bloomberg | Moderna, Novavax Have More Upside Potential Than Big Pharma if Vaccine is Approved
Canada now has a total of four purchase agreements with various biotech and pharmaceutical companies to supply the country with millions of COVID-19 vaccine doses, subject to their Health Canada approval. The purchase agreements with Pfizer, Moderna Therapeutics, Novavax and Johnson and Johnson will give Canadians better access to some of the promising vaccine candidates currently under development.
Brian Bloom discusses this and more with Catherine Murray of BNN Bloomberg.
Watch the full interview here.
